Literature DB >> 6668318

Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography.

C L Golas, C G Prober, S M MacLeod, S J Soldin.   

Abstract

A high-performance liquid chromatographic method for the analysis of amphotericin B in 25 microliters of serum or plasma is described. The procedure involves the addition of the internal standard, p-nitrobenzyloxyamine, to the sample followed by a precipitation of protein with acetonitrile. The supernatant is directly injected into a chromatograph attached to a reversed-phase mu Bondapak (Waters) column containing C18 packing. The mobile phase is a 60 : 40 mixture of a sodium acetate buffer (10 mM, pH 7.0)--acetonitrile, and we employ a flow-rate of 1.5 ml/min and a detection wavelength of 405 nm. Total analysis time per sample is 10 min. Coefficients of variation were found to be less than 4% for concentrations less than 2 mg/l. Analytical recoveries were between 75 and 80%. No drug or drug metabolite interference was found. The method will be used to study pharmacokinetic and pharmacodynamic data in a pediatric population.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6668318     DOI: 10.1016/s0378-4347(00)84798-2

Source DB:  PubMed          Journal:  J Chromatogr


  8 in total

1.  Poor and unusually prolonged oral absorption of amphotericin B in rats.

Authors:  G Robbie; T C Wu; W L Chiou
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Rapid determination of amphotericin B levels in serum by high-performance liquid chromatography without interference by bilirubin.

Authors:  H Hosotsubo; J Takezawa; N Taenaka; K Hosotsubo; I Yoshiya
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

3.  Quantitative extraction of amphotericin B from serum and its determination by high-pressure liquid chromatography.

Authors:  P R Bach
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

4.  Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.

Authors:  C E Nath; P J Shaw; R Gunning; A J McLachlan; J W Earl
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.

Authors:  G Robbie; W L Chiou
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

6.  Flow cytometric assay for estimating fungicidal activity of amphotericin B in human serum.

Authors:  E Martin; U Schlasius; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

7.  Fungicidal effect of amphotericin B in urine: in vitro study to assess feasibility of bladder washout for localization of site of candiduria.

Authors:  I W Fong; P C Cheng; N A Hinton
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard.

Authors:  G G Granich; G S Kobayashi; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.